Faiza Iqbal

Faiza Iqbal

Auto-generated profile, based on publicly available information

Faiza Iqbal

Department of Paediatrics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2024 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
FIFaiza Iqbal
Faiza Iqbal
AAArya Alocious
Arya Alocious
SJSelin C. Joy
Selin C. Joy
ESElstin Anbu Raj S
Elstin Anbu Raj S
VRV. Rajesh
V. Rajesh
PCPrashant Chandra
Prashant Chandra

21 July 2025 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
FIFaiza Iqbal
Faiza Iqbal
PSPadmaja Ananth Shenoy
Padmaja Ananth Shenoy
LLLeslie Edward Lewis
Leslie Edward Lewis
NSN. Siva
N. Siva
JPJayashree Purkayastha
Jayashree Purkayastha
VEVandana Kalwaje Eshwara
Vandana Kalwaje Eshwara
Introduction: Given the significant role of the gut microbiota in early immune and metabolic development, the impact of perinatal antibiotic administration on the neonatal gut microbiome remains a crucial area of investigation. This study examines how maternal and neonatal antibiotic exposure affects the composition of the gut microbiome in preterm infants. Methodology: A prospective controlled cohort study was conducted in the neonatal intensive care unit of a tertiary care hospital from January 2021 to September 2023. The study enrolled neonates with a gestational age of less than 37 weeks. Preterm infants were categorized into four groups based on exposure to maternal or neonatal antibiotics: the NE group (no exposure), IE group (infant exposure only), ME group (maternal exposure only), and IME group (both infant and maternal exposure). In the NE group, “No exposure” refers to participants whose mothers did not receive intrapartum antibiotics or whose neonates were not administered postnatal antibiotics prior to sample collection. Data on antibiotic use and microbiota composition from stool samples were collected and analyzed via the convection culture method. Results: This study included 182 preterm infants, yielding 364 stool samples. By day 4, the prevalence of Klebsiella pneumoniae increased significantly, reaching 70% in the IE group compared with 42.6% in the NE group (p < 0.001). Bifidobacterium spp. was more prevalent in the NE group than in the other groups on day 4 (57.4%, p = 0.019). The antibiotic-exposed groups (IE, ME, and IME groups) presented greater abundances of potentially pathogenic bacteria, such as Klebsiella pneumoniae and Escherichia coli, whereas beneficial bacteria, such as Bifidobacterium spp., were more abundant in the NE group. Conclusion: These findings suggest that perinatal antibiotic exposure is associated with significant changes in the neonatal gut microbiota, potentially increasing the pathogenic microbiota. Trial registration: The study was registered with the Clinical Trials Registry-India (CTRI) under the number CTRI/2020/11/029375 |http://ctri.nic.in/ on November 19, 2020.

8 August 2023 in Journal of Neonatal Nursing
Verified
Journal Article
Closed access
FIFaiza Iqbal
Faiza Iqbal
PCPrashant Chandra
Prashant Chandra
LLLeslie Edward Lewis
Leslie Edward Lewis
DADinesh Acharya
Dinesh Acharya
JPJayashree Purkayastha
Jayashree Purkayastha
APAnand Kumar Patil
Anand Kumar Patil

13 September 2024 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
Y.Ysphaneendramallimoggala .
Ysphaneendramallimoggala .
MBMonalisa Biswas
Monalisa Biswas
ESElstin Anbu Raj S
Elstin Anbu Raj S
FIFaiza Iqbal
Faiza Iqbal
SAShrikiran A.
Shrikiran A.
LLLeslie Edward Lewis
Leslie Edward Lewis
The sustainable developmental goals emphasize good health, reduction in preventable neonatal and under-five mortalities, and attaining zero hunger. However, South Asian countries report a higher incidence of neonatal and under-five mortalities when compared to the Western world, many of which are attributed to maternal and perinatal micronutrient deficiencies. Isolated nutrient deficiency in the absence of calorie deficit poses a diagnostic challenge since such deficiencies present with acute multisystemic and enigmatic manifestations. Thiamine (vitamin B1) is a micronutrient of prime importance which exerts indispensable roles in energy metabolism. Deficiency of thiamine can lead to catastrophic consequences. This review provides insight into the biochemical actions of thiamine in energy metabolism, the compromised aerobic metabolism resulting from thiamine deficiency, and the crucial role of thiamine in the proper functioning of the nervous, cardiovascular, and immune systems. The review also explores the acute life-threatening consequences of thiamine deficiencies in neonates and infants and the speculative role of thiamine in other pathologies like encephalopathy, sepsis, and autism spectrum disorders. However, routine assessment of thiamine in pregnant women and neonates is yet to be implemented, due to the lack of affordable and automated diagnostic techniques, and the cost-intensive nature of mass spectrometry-based quantification. Conclusion: Physicians are recommended to have a low threshold for suspecting thiamine deficiency especially in vulnerable populations. Laboratory diagnosis of thiamine deficiency needs to be implemented as a standard of care, especially in endemic regions. Further, public health policies on food fortification, mandatory supplementation, and surveillance are imperative to eliminate thiamine deficiency-induced health hazards. What is Known:• South Asian countries report a higher incidence of neonatal and under-five mortalities, many of which are attributed to maternal and perinatal micronutrient deficiencies.• Preventable causes of neonatal/ infantile deaths include birth factors (low birth weight, birth asphyxia), infectious diseases (pneumonia, diarrhoea, tetanus, tuberculosis, measles, diphtheria, malaria, acute infections), deficiency diseases and genetic diseases (vitamin & mineral deficiencies, IEMs, congenital heart disease, unexplained PPHN, SIDS etc). What is New:• Acute thiamine deficiency presenting as multisystemic syndromes, has unfortunately been a long standing unresolved public health concern. However, accessible surveillance and diagnostic strategies remain elusive in most clinical settings.• Despite decades of reports and emerging guidelines, diagnosis of thiamine deficiency is often missed and policy mandates at national level are yet to be implemented even in endemic countries.• This review provides a comprehensive summary of the biochemical role of thiamine, its key functions and effects on major organ systems, the diagnostic gap, the enigmatic presentation of acute thiamine deficiency, the plausible role of thiamine in other pathologies and the preventive measures at individual and community level.

12 November 2024 in Journal of Neonatal Nursing
Verified
Journal Article
Open access
SBShruthi K. Bharadwaj
Shruthi K. Bharadwaj
FIFaiza Iqbal
Faiza Iqbal

31 January 2023 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
PDF file
FIFaiza Iqbal
Faiza Iqbal
LLLeslie Edward Lewis
Leslie Edward Lewis
NSN. Siva
N. Siva
VEVandana Kalwaje Eshwara
Vandana Kalwaje Eshwara
JPJayashree Purkayastha
Jayashree Purkayastha
PSPadmaja Ananth Shenoy
Padmaja Ananth Shenoy
Introduction Billions of microorganisms reside in gut altering its homeostasis and leading to various diseases. The initial days of life are crucial for developing gut flora that helps in gut maturation and neonatal health. This review summarizes the evidence on seeding of neonatal gut microbiota, modulation of gut microbiota in neonatal sepsis, antimicrobial resistance, and role of probiotics or other therapies to re-establish altered microbiota. Conclusion Gut microbiota regulates host physiological homeostasis mediators, including the gut barrier function, and disease susceptibility pathways. Maintenance or restoration of microbiota and metabolite composition may be a therapeutic or preventative target against critical illness.